Life Sciences Information Technology (IT) Market Report 2026

The life sciences information technology (it) market size has grown rapidly in recent years. It will grow from $29.14 billion in 2025 to $33.3 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of digital data generation in life sciences, increasing complexity of clinical trial management, adoption of electronic laboratory systems, growth of bioinformatics research, rising regulatory data requirements.

The life sciences information technology (it) market size is expected to see rapid growth in the next few years. It will grow to $56.16 billion in 2030 at a compound annual growth rate (CAGR) of 14%. The growth in the forecast period can be attributed to increasing investments in cloud-native life science IT, rising adoption of AI-driven bioinformatics, expansion of interoperable healthcare data platforms, growing demand for real-time research collaboration tools, increasing focus on cybersecurity in life sciences. Major trends in the forecast period include increasing adoption of integrated life science it platforms, rising use of cloud-based laboratory systems, growing deployment of bioinformatics solutions, expansion of digital clinical trial management tools, enhanced focus on data security and compliance.

The increasing prevalence of chronic diseases is expected to drive the growth of the life science information technology (IT) market in the coming years. Chronic diseases are long-term health conditions that persist over extended periods, often for a person’s lifetime, and generally progress gradually, such as diabetes, cardiovascular disease, and chronic respiratory disorders. The rise in chronic diseases is attributed to factors including aging populations, sedentary lifestyles, poor dietary habits, higher rates of obesity, and environmental influences. Life science IT plays a crucial role in managing chronic diseases by enabling comprehensive data management, supporting personalized treatment plans, and enhancing patient monitoring and outcomes through advanced analytics and integrated health information systems. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based medical library, reported that the number of individuals aged 50 and above with one or more chronic conditions is projected to increase by 99.5% by 2050, rising from 71.52 million in 2020 to 142.66 million. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the life science information technology (IT) market.

Major companies operating in the life sciences information technology (IT) market are concentrating on creating technologically advanced solutions, such as cloud-native SaaS platforms, to provide scalable, cost-effective, and compliant tools that improve collaboration, data integration, and the pace of innovation. A cloud-native SaaS platform refers to software-as-a-service applications specifically designed to operate in cloud environments, utilizing cloud infrastructure for scalability, flexibility, and reliability. For example, in June 2023, Revvity Inc., a US-based biotechnology company, introduced the Signals Research Suite, a cloud-native SaaS platform aimed at enhancing scientific collaboration in drug discovery and specialty chemicals development. The suite integrates applications like Signals Notebook, VitroVivo, and Inventa, offering comprehensive support throughout the entire drug development process, from early research to in vitro testing and safety evaluations. The Signals Research Suite is notable for its scientifically intelligent, integrated software applications that fully support the Make-Test-Decide lifecycle. Its key features include advanced analytics and visualizations powered by TIBCO Spotfire, seamless integration with the industry-standard ChemDraw, and a modern, streamlined interface that customizes workflows across multiple techniques, modalities, and datatypes. With secure single-sign-on access, centralized data resources, tutorials, and software updates, users can efficiently focus on experiments without needing to navigate between separate solutions.

In January 2024, DNAnexus Inc., a US-based precision health data cloud provider, collaborated with Intelliseq to integrate clinical reporting and automated genomic variance interpretation capabilities into the precision health data cloud. This collaboration is designed to streamline next-generation sequencing data analysis, offer insights into somatic cancers and hereditary diseases, and allow DNAnexus customers to access Intelliseq's tertiary analysis tools directly within the Precision Health Data Cloud. Intelliseq is a Poland-based provider of life sciences IT solutions.

Major companies operating in the life sciences information technology (it) market are Veeva Systems Inc., Medidata Solutions Inc., Oracle Corporation, SAP SE, International Business Machines Corporation, Microsoft Corporation, Accenture plc, Cognizant Technology Solutions Corporation, Dassault Systèmes SE, SAS Institute Inc., PTC Inc., Infor Inc., LabWare Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Certara Inc., IQVIA Holdings Inc., ArisGlobal LLC, Dotmatics Limited, Benchling Inc.

North America was the largest region in the life sciences information technology (IT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life sciences information technology (it) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life sciences information technology (it) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the life sciences IT market by increasing costs of imported servers, networking equipment, data storage hardware, and specialized IT infrastructure supporting laboratory and clinical systems. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on global IT supply chains, while Asia-Pacific faces pricing pressure on exported IT services. These tariffs are increasing implementation costs and slowing IT modernization initiatives. At the same time, they are encouraging cloud migration, regional data center investments, and local IT service partnerships.

The life sciences information technology (it) market research report is one of a series of new reports that provides life sciences information technology (it) market statistics, including life sciences information technology (it) industry global market size, regional shares, competitors with a life sciences information technology (it) market share, detailed life sciences information technology (it) market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences information technology (it) industry. This life sciences information technology (it) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Life sciences information technology (IT) involves the use of information technology (IT) systems and solutions specifically created to support and improve different aspects of life sciences research, development, and operations. This area includes a variety of technologies and tools that enable effective data management, analysis, and communication across life sciences sectors, such as pharmaceuticals, biotechnology, and medical research.

The primary components of life sciences information technology (IT) are software and services. Life sciences IT software consists of specialized technologies and applications developed to support and enhance research, development, and management processes in fields such as biotechnology, pharmaceuticals, and healthcare. It offers a range of solutions, including drug discovery informatics, clinical trial management, bioinformatics, laboratory information management, and more, and is utilized by various end users, such as pharmaceutical and biotechnology companies, contract research and development organizations, and others.

The life science information technology (IT) market consists of revenues earned by entities by providing services such as electronic lab notebooks (ELN) integration, regulatory compliance consulting, health information management and clinical data integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The life science information technology (IT) market also includes sales of data analytics platforms, custom research software, cloud-based data solutions and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.